ArticleKidney international2017

Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients.

Stephen P McAdoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.